Properties and applications of photodynamic therapy.

Photodynamic therapy (PDT) is the treatment of malignant lesions with visible light following the systemic administration of a tumor-localizing photosensitizer. Pharmacological and photochemical properties of the photosensitizer are combined with precise delivery of laser-generated light to produce a treatment which can offer selective tumoricidal action. Hematoporphyrin derivative (HD) and a purified component called Photofrin II are currently being used in clinical PDT. Initial patient results have been encouraging, and considerable interest has developed in the synthesis and evaluation of new photosensitizers with improved photochemical and pharmacological characteristics. In addition, there has been a gradual increase in knowledge related to in vitro and in vivo mechanisms of action of PDT. This report provides an overview of the properties and applications of PDT. Information and data related to drug development, photochemistry, subcellular targets, in vivo responses, and clinical trials of PDT are presented.

[1]  A. Girotti,et al.  Role of lipid peroxidation in hematoporphyrin derivative-sensitized photokilling of tumor cells: protective effects of glutathione peroxidase. , 1989, Cancer research.

[2]  T. Dougherty,et al.  CARBON‐14 LABELING AND BIOLOGICAL ACTIVITY OF THE TUMOR‐LOCALIZING DERIVATIVE OF HEMATOPORPHYRIN , 1988, Photochemistry and photobiology.

[3]  N. Oleinick,et al.  INDUCTION OF DNA‐PROTEIN CROSS‐LINKS IN CHINESE HAMSTER CELLS BY THE PHOTODYNAMIC ACTION OF CHLOROALUMINUM PHTHALOCYANINE AND VISIBLE LIGHT , 1988, Photochemistry and photobiology.

[4]  C J Gomer,et al.  Differential cell photosensitivity following porphyrin photodynamic therapy. , 1988, Cancer research.

[5]  M W Berns,et al.  In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. , 1988, Journal of the National Cancer Institute.

[6]  Chi-Wei Lin,et al.  Photodynamic Therapy With Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the Bladder , 1988 .

[7]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[8]  G. Hahn,et al.  Isolation and initial characterization of thermoresistant RIF tumor cell strains. , 1988, Cancer research.

[9]  C J Gomer,et al.  Transformation and mutagenic potential of porphyrin photodynamic therapy in mammalian cells. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[10]  R. Keck,et al.  New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors. , 1988, Cancer research.

[11]  Amy S. Lee,et al.  Regulation of the glucose‐regulated protein genes by β‐mercaptoethanol requires de novo protein synthesis and correlates with inhibition of protein glycosylation , 1987, Journal of cellular physiology.

[12]  R. Keck,et al.  MORPHOLOGICAL CHANGES OF TUMOR MICROVASCULATURE FOLLOWING HEMATOPORPHYRIN DERIVATIVE SENSITIZED PHOTODYNAMIC THERAPY * , 1987, Photochemistry and photobiology.

[13]  M. Berns,et al.  TUMOR DESTRUCTION IN PHOTODYNAMIC THERAPY , 1987, Photochemistry and photobiology.

[14]  M W Berns,et al.  In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. , 1987, Cancer research.

[15]  D. Kessel,et al.  Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. , 1987, Cancer research.

[16]  C. Gomer,et al.  The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. , 1987, British Journal of Cancer.

[17]  A. Girotti,et al.  Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. , 1987, Cancer letters.

[18]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[19]  A. Oseroff,et al.  Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Müller,et al.  Predicting the response of obstructive endobronchial tumors to photodynamic therapy , 1986, Cancer.

[21]  D. Kessel.  SITES OF PHOTOSENSITIZATION BY DERIVATIVES OF HEMATOPORPHYRIN , 1986, Photochemistry and photobiology.

[22]  G. Jori,et al.  Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. , 1986, Cancer letters.

[23]  C. Gomer,et al.  Expression of potentially lethal damage in Chinese hamster cells exposed to hematoporphyrin derivative photodynamic therapy. , 1986, Cancer research.

[24]  M R Arnfield,et al.  Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole. , 1986, Cancer research.

[25]  J. Spikes.  PHTHALOCYANINES AS PHOTOSENSITIZERS IN BIOLOGICAL SYSTEMS AND FOR THE PHOTODYNAMIC THERAPY OF TUMORS , 1986, Photochemistry and photobiology.

[26]  W. Star,et al.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.

[27]  M S Patterson,et al.  The physics of photodynamic therapy. , 1986, Physics in medicine and biology.

[28]  D. Kessel,et al.  DIRECT DETECTION OF SINGLET OXYGEN SENSITIZED BY HAEMATOPORPHYRIN AND RELATED COMPOUNDS , 1986, Photochemistry and photobiology.

[29]  G. Li,et al.  Heat-resistant variants of Chinese hamster fibroblasts altered in expression of heat shock protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T J Dougherty,et al.  TIME and SEQUENCE DEPENDENT INFLUENCE OF IN VITRO PHOTODYNAMIC THERAPY (PDT) SURVIVAL BY HYPERTHERMIA , 1985, Photochemistry and photobiology.

[31]  M W Berns,et al.  Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation. , 1985, Cancer research.

[32]  E. Land,et al.  Porphyrin localization and treatment of tumors , 1985, British Journal of Cancer.

[33]  C. Gomer,et al.  Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. , 1985, Cancer research.

[34]  Photoradiation therapy of endobronchial lung cancer. Large obstructing tumors, nonobstructing tumors, and early-stage bronchial cancer lesions. , 1985 .

[35]  D. Bellnier,et al.  Photosensitization and split-dose recovery in cultured human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative. , 1985, Cancer research.

[36]  C. Gomer,et al.  In vitro and in vivo light dose rate effects related to hematoporphyrin derivative photodynamic therapy. , 1985, Cancer research.

[37]  W. Degraff,et al.  Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells. , 1985, Cancer research.

[38]  J Moan,et al.  Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.

[39]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[40]  G. Buettner,et al.  Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light. , 1985, Cancer letters.

[41]  E. Reddi,et al.  Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. , 1984, Cancer letters.

[42]  D. Tse,et al.  Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. , 1984, Archives of ophthalmology.

[43]  S. Britton,et al.  Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. , 1984, Cancer research.

[44]  S. Gibson,et al.  Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats. , 1984, Cancer research.

[45]  C J Gomer,et al.  ACTION SPECTRUM (620–640 nm) FOR HEMATOPORPHYRIN DERIVATIVE INDUCED CELL KILLING , 1984, Photochemistry and photobiology.

[46]  T J Dougherty,et al.  Interaction of hyperthermia and photoradiation therapy. , 1984, Radiation research.

[47]  N. Miyoshi,et al.  Photoradiation therapy of bladder tumors. , 1983, The Journal of urology.

[48]  Foote Cs.  Mechanisms of photooxygenation. , 1984 .

[49]  U. Löhrs,et al.  Integral dye-laser irradiation of photosensitized bladder tumors with the aid of a light-scattering medium. , 1984, Progress in clinical and biological research.

[50]  C. Gomer,et al.  Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation. , 1983, Cancer research.

[51]  H. Kato,et al.  Fiberoptic bronchoscopic photoradiation in experimentally induced canine lung cancer , 1983, Cancer.

[52]  J. H. Kinsey,et al.  Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative. , 1982, Mayo Clinic proceedings.

[53]  T. Dougherty,et al.  MEMBRANE LYSIS IN CHINESE HAMSTER OVARY CELLS TREATED WITH HEMATOPORPHYRIN DERIVATIVE PLUS LIGHT , 1982, Photochemistry and photobiology.

[54]  J. Moan,et al.  Uptake of hematoporphyrin derivative and sensitized photoinactivation of C3H cells with different oncogenic potential. , 1981, Cancer letters.

[55]  T. Dougherty,et al.  Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.

[56]  R. E. Thoma,et al.  Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. , 1981, Cancer research.

[57]  C J Gomer,et al.  DNA damage and repair in CHO cells following hematoporphyrin photoradiation. , 1980, Cancer letters.

[58]  C. Gomer,et al.  PHOTOINACTIVATION OF CHINESE HAMSTER CELLS BY HEMATOPORPHYRIN DERIVATIVE AND RED LIGHT , 1980, Photochemistry and photobiology.

[59]  P. V. Hariharan,et al.  Production of hydroxyl radicals in cell systems exposed to haematoporphyrin and red light. , 1980, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[60]  T. Dougherty,et al.  Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.

[61]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[62]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[63]  A. M. Olsen,et al.  The use of a derivative of hematoporphyrin in tumor detection. , 1961 .

[64]  F. Figge,et al.  Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.